Quoin Pharmaceuticals QNRX Income Statement (2016-2026)

NASDAQ QNRX
$3.90 +0.27 (+7.44%)
At close: Nov 9, 2026 · 4:00 PM EST
Reported Financials

Quoin Pharmaceuticals Quarterly Income Statement

Periods 30 quarters
Latest Sep 2026

Quoin Pharmaceuticals reported net income of -$4.87M for the quarter ended Sep 2026. This income statement covers 30 quarters of results from Dec 2016 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Dec2016 Dec2017 Jun2018 Dec2018 Jun2019 Dec2019 Jun2020 Dec2020 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating items
Operating Interest ExpensesOp. Interest Exp.
Research & DevelopmentR&D
1.01M0.59M0.73M0.75M0.61M1.09M0.63M0.76M0.83M0.89M0.59M1.08M1.05M2.37M2.05M2.28M3.10M3.43M3.63M2.66M
Selling, General & AdministrativeSG&A
1.97M1.59M1.94M1.58M1.47M1.68M1.63M1.37M1.39M1.57M1.55M1.45M1.35M1.58M1.74M1.74M1.42M1.70M1.85M2.27M
Operating ExpensesOpex
2.98M2.18M2.67M2.33M2.09M2.78M2.26M2.13M2.22M2.46M2.14M2.53M2.41M3.96M3.79M4.02M4.52M5.13M5.47M4.92M
Non-operating items
Non Operating Interest Expenses
Interest & Investment IncomeInt & Inv Inc
0.02M0.08M0.15M0.19M0.20M0.14M0.10M0.15M0.10M0.13M
Other Non Operating IncomeOther Non Op Inc.
-4.52M0.42M0.00M0.00M0.02M-0.03M0.00M0.01M-0.01M0.00M0.03M-0.02M126.00-0.01M0.01M364.00-0.01M0.00M-0.07M
Non Operating IncomeNon Op. Inc.
-8.84M0.49M-0.70M0.08M0.17M0.15M0.20M0.17M0.13M0.16M0.18M0.09M0.14M0.10M0.07M0.17M0.13M0.10M0.05M
Net income details
Income towards Parent CompanyParent Net Inc
-11.82M-1.68M-2.67M-3.03M-2.00M-2.60M-2.11M-1.93M-2.05M-2.33M-1.97M-2.35M-2.31M-3.81M-3.70M-3.95M-4.30M-5.00M-5.37M-4.87M
Net Income towards Common StockholdersNet Income
-11.82M-1.68M-2.67M-3.09M-2.00M-2.60M-2.11M-1.93M-2.05M-2.33M-1.97M-2.35M-2.31M-3.81M-3.70M-3.95M-4.30M-5.00M-5.37M-4.87M
Additional items
EPS (Basic)
-0.26-87.790.00M-394.87-28.92-11.91-74.70-68.31-79.64-38.73-13.68-16.29-17.25-227.56-219.93-234.94-141.05-61.79-66.36-33.81
EPS (Diluted)
-0.26-87.790.00M-394.87-28.92-11.91-74.70-68.31-79.64-38.73-13.68-16.29-17.25-227.56-219.93-234.94-141.05-61.79-66.36-33.81
Shares Outstanding
45.28M0.02M0.00M0.01M0.07M0.22M0.03M0.03M0.03M0.06M0.14M0.14M0.13M0.02M0.02M0.02M0.03M0.08M0.08M0.14M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
45.28M0.02M0.00M0.01M0.07M0.22M0.03M0.03M0.03M0.06M0.14M0.14M0.13M0.02M0.02M0.02M0.03M0.08M0.08M0.14M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
45.28M0.02M0.00M0.01M0.07M0.22M0.03M0.03M0.03M0.06M0.14M0.14M0.13M0.59M0.59M0.59M1.07M2.83M2.83M4.80M
Interest ExpensesInt Expense

Quoin Pharmaceuticals Income Statement API

Pull Quoin Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=QNRX&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY